Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia

Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia

Cardiac resynchronization therapy (CRT) is a new treatment for refractory heart failure. However, most patients with heart failure treated with CRT are adults, middle-aged or older with idiopathic or ischemic dilated cardiomyopathy. We treated a 12-year-old boy, who was transferred after cardiac a...

Full description

Bibliographic Details
Main Authors:	Hak Ju Kim, Sungkyu Cho, Woong-Han Kim
Format:	Article
Language:	English
Published:	Korean Society for Thoracic and Cardiovascular Surgery 2016-08-01
Series:	Korean Journal of Thoracic and Cardiovascular Surgery
Subjects:	Arrhythmia Heart failure Cardiomyopathy Cardiac resynchronization therapy Defibrillator
Online Access:	http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2016.49.4.292

Similar Items

Evaluation of QRS dispersion and its association withtachyarrhythmia events in patients with implantedcardiac resynchronization therapy defibrillator device
by: Fariborz Akbarzadeh, et al.
Published: (2018-03-01)

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
by: Simon Christie, et al.
Published: (2019-02-01)

Influence of the Right Ventricular Lead Location on Ventricular Arrhythmias in Cardiac Resynchronization Therapy
by: Hao Su, et al.
Published: (2018-01-01)

Evaluation of Left Ventricular Endocardial Cardiac Resynchronization Therapy in a Non-responder with Ventricular Arrhythmias
by: Masih Mafi Rad, MD, et al.
Published: (2014-01-01)

Current status of cardiac resynchronization therapy with defibrillators and factors influencing its prognosis in Japan
by: Akihiko Shimizu, et al.
Published: (2013-06-01)

The current status of cardiac resynchronization therapy and implantable cardioverter defibrillator in China
by: Xiaohan Fan, et al.
Published: (2016-01-01)

Role of QT dispersion and Tp-e interval after biventricular pacing in the incidence of sustained ventricular arrhythmias in patients with implanted cardiac resynchronization therapy device
by: Fariborz Akbarzadeh, et al.
Published: (2017-11-01)

Cardiac Resynchronization Therapy: Who Benefits?
by: Jason S. Chinitz, et al.
Published: (2014-04-01)

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden
by: Gadler F, et al.
Published: (2016-10-01)

Ventricular Arrhythmia Discriminator Programming and the Impact on the Incidence of Inappropriate Therapy in Patients with Implantable Cardiac Defibrillators
by: Ulrika Birgersdotter-Green, et al.
Published: (2007-04-01)

Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators
by: Marie Christine Iliou, et al.
Published: (2016-10-01)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
by: Hisashi Yokoshiki, MD, PhD, et al.
Published: (2017-10-01)

Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
by: Tal Hasin, et al.
Published: (2021-04-01)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2020-08-01)

Implantation of a cardiac resynchronization therapy and defibrillation system using a robotic approach
by: Sana Amraoui, MD, et al.
Published: (2015-09-01)

Interventional challenges due to venous occlusion during cardiac resynchronization therapy in patients with prior cardioverter-defibrillator implantation: Case report
by: Veysel Kutay Vurgun, et al.
Published: (2016-07-01)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
by: Fang Shawn Foo, et al.
Published: (2020-02-01)

A case of premature ventricular contractions, ventricular tachycardia, and arrhythmic storm induced by right ventricular pacing during cardiac resynchronization therapy: Electrophysiological mechanism and catheter ablation
by: Stefano Pedretti, MD, et al.
Published: (2015-12-01)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
by: Finn Akerström, et al.
Published: (2020-05-01)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
by: Thomas Beiert, et al.
Published: (2018-04-01)

Association between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease
by: Bárbara Carolina Silva Almeida, et al.
Published: (2018-04-01)

Cardiac resyncronization therapy with or without cardioverter-defibrillator versus defibrillator therapy alone, Pereira (Colombia): a cohort study
by: Arango- Franco, Ricardo, et al.
Published: (2016-04-01)

Cardiac resynchronization therapy in a case with single ventricle and concommitant noncompaction cardiomyopathy
by: Deniz Elçik, et al.
Published: (2020-03-01)

Late Ratchet syndrome involving isolated left ventricular lead dislodgement post‐cardiac resynchronization therapy defibrillator generator change
by: Vern Hsen Tan, et al.
Published: (2018-04-01)

2015 ESC GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND THE PREVENTION OF SUDDEN CARDIAC DEATH
by: Priori G. Silvia, et al.
Published: (2016-07-01)

Triple atrial sensing during cardiac resynchronization
by: S. Serge Barold, et al.
Published: (2020-02-01)

Hybrid subcutaneous and transvenous approach for cardiac resynchronization defibrillator implant in a patient with congenital heart disease and tricuspid bioprosthetic
by: Pooneh Nabavizadeh, MD, et al.
Published: (2020-01-01)

Characterization of Suitability of Coronary Venous Anatomy for Targeting Left Ventricular Lead Placement in Patients Undergoing Cardiac Resynchronization Therapy
by: Parin Yazdanifard, et al.
Published: (2012-03-01)

Characterization of Suitability of Coronary Venous Anatomy for Targeting Left Ventricular Lead Placement in Patients Undergoing Cardiac Resynchronization Therapy
by: Ahmad Yaminisharif, et al.
Published: (2012-01-01)

Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up
by: Stefan Warpechowski Neto, et al.
Published: (2019-02-01)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
by: Alwin B. P. Noordman, et al.
Published: (2021-08-01)

The effectiveness of the cardiac resynchronization in a patient with ischemic cardiomyopathy
by: Diana R. Tudorașcu, et al.
Published: (2018-04-01)

Upgrade to cardiac resynchronization therapy difibrillator device of a pacemaker-dependent patient with end-stage hypertrophic cardiomyopathy
by: E. Solomou, et al.
Published: (2020-01-01)

Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2016-12-01)

Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report
by: Jun yi Wang, et al.
Published: (2019-04-01)

Prospective observational study on predicting adverse clinical outcomes in patients with implanted defibrillating devices – a study rationale, design and principal methods
by: Przemysław Guzik, et al.
Published: (2014-03-01)

Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations
by: Antonino M. Grande, MD, et al.
Published: (2015-12-01)

Anxiety, depression and cardiac anxiety in patients with implantable cardioverter-defibrillator according to gender and age
by: Isabelle Brigliadori Ignácio, et al.
Published: (2021-02-01)

Hybrid implantation of Cardiac resynchronization therapy device
by: Alexander Edo Tondas, et al.
Published: (2013-06-01)

Benefit of magnetic resonance–conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis–involved cervical extradural lesion
by: Hiroshi Kawakami, MD, et al.
Published: (2016-01-01)